TRENDING:

Oil price

XAU/USD

Mid-afternoon market update: Dow surges over 100 points; Provention Bio (PRVB Stock) shares plunge

Benzinga Team Benzinga

Toward the end of trading Friday, the Dow traded up 0.42% to 33,645.90 while the NASDAQ rose 0.06% to 13,837.33. The S&P also rose, gaining 0.32% to 4,110.11.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 31,003,070 cases with around 560,110 deaths. Brazil reported over 13,279,850 COVID-19 cases with 345,020 deaths, while India confirmed a total of at least 13,060,540 cases and 167,640 deaths. In total, there were at least 134,038,180 cases of COVID-19 worldwide with more than 2,904,550 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Consumer discretionary shares rose 0.7% on Friday. Meanwhile, top gainers in the sector included China Online Education Group COE 9.78%, up 11%, and Natuzzi S.p.A. NTZ 16.12%, up 15%.

In trading on Friday, consumer staples shares fell 0.6%.

Top Headline

Producer prices for final demand increased 1% in March after a 0.5% rise in January. However, analysts were expecting for a 0.5% rise.

Equities Trading UP

Celcuity Inc. CELC 44.23% shares shot up 46% to $20.88 after the company announced a worldwide licensing agreement with Pfizer to develop and commercialize gedatolisib. Separately, Celcuity reported positive preliminary data for the 103 patients enrolled in the expansion portion of an ongoing Phase 1b clinical trial evaluating gedatolisib, plus Ibrance and endocrine therapy, in ER+/HER2- advanced or metastatic breast cancer patients.

Shares of Affimed N.V. AFMD 23.58% got a boost, shooting 22% to $9.64 after the company announced initial clinical data from an investigator-sponsored study evaluating cord blood-derived natural killer (cbNK) cells pre-complexed with Affimed's innate cell engager (ICE) AFM13 (CD16A/CD30).

fuboTV Inc. FUBO 11.84% shares were also up, gaining 13% to $23.43 after the company announced it acquired exclusive streaming rights to the Qatar World Cup 2022 Qualifying matches of South American Football Confederation.

Check out these big movers of the day

Equities Trading DOWN

Novo Integrated Sciences, Inc. NVOS 24.27% shares tumbled 23% to $2.7450 after the company reported pricing of $8 million registered direct offering at $3.35 per share.

Shares of WD-40 Company WDFC 12.21% were down 15% to $262.92 after the company reported downbeat Q2 results.

Provention Bio, Inc. PRVB 17.93% was down, falling 18% to $8.01 after the company said it has been notified by the FDA that it has identified deficiencies in the company's biologic license application for teplizumab for the delay or prevention of clinical type 1 diabetes. The identified deficiencies preclude discussion of labeling and post-marketing requirements/commitments at this time, the company said, citing the FDA.

Commodities

In commodity news, oil traded down 0.3% to $59.43, while gold traded down 0.7% to $1,745.50.

Silver traded down 1.1% Friday to $25.31 while copper fell 1.3% to $4.0410.

Euro zone

European shares closed mixed today. The eurozone’s STOXX 600 rose 0.08%, the Spanish Ibex Index fell 0.83% and the German DAX 30 gained 0.21%. Meanwhile, the French CAC 40 rose 0.06%, London’s FTSE 100 fell 0.38% and Italy’s FTSE MIB fell 0.60%.

UK’s Halifax house price index increased 6.5% year-over-year in March. Spain's industrial production fell 2.1% from a year ago in February, while industrial production in France dropped 4.7% in February.

German current account surplus shrank to EUR 18.8 billion in February from EUR 20.2 billion in the year-ago month, while trade surplus narrowed to €18.1 billion from €20.3 billion. Industrial production in Germany declined 1.6% in February.

Economics

Producer prices for final demand increased 1% in March after a 0.5% rise in January. However, analysts were expecting for a 0.5% rise.

Wholesale inventories in the US rose 0.6% in February following a 1.4% increase in January.

The total number of active U.S. oil rigs came in unchanged at 337 rigs this week, Baker Hughes Inc reported.

Author

Benzinga Team

Benzinga

Benzinga's news desk is a dynamic and innovative team that provides real-time, actionable articles that help readers navigate the market.

GBP/USD: Daily gains remain capped by 1.3650

GBP/USD leaves behind Monday’s pessimism and advances marginally on Tuesday. Cable’s humble gains, however, appear to have met quite a decent resistance in the 1.3650 zone for now, in a context of a slight selling pressure hovering around the Greenback.

EUR/USD struggles to regain pace; gyrates around 1.1670

EUR/USD clinches humble gains around 1.1670 following Tuesday’s close on Wall Street. Indeed, marginal losses in the US Dollar encourages spot to set aside two dauly pullbacks in a row and maintain the 1.1700 barrier on the cross-hairs for now. Moving forward, US inflation tracked by the PCE and another revision of Q2 GDP data should keep investors entertained on Wednesday.

Gold struggles near $4,650 ahead of US PCE inflation data

Gold struggles around $4,650 early Wednesday after the previous day's two-way swings as traders await the US PCE data for cues about the Fed's interest rate path. The outlook could drive the US Dollar and the non-yielding bullion. Meanwhile, renewed hopes for a US-Iran peace deal, weak Oil prices, sliding US bond yields and diminishing odds of an immediate tightening by the Fed undermine the USD, which could likely limit Gold's downside.

Bitcoin posts strongest weekly gain since November 2024 as market activity surges

Bitcoin (BTC) has posted its strongest one-week gain since the November 2024 US presidential election, climbing 23% over the past week as spot market activity and institutional demand returned sharply, according to a Tuesday report from K33. The rally pushed Bitcoin from around $63,000 to over $80,000 by late Monday.

America’s self‑inflicted trade wound

I’m conflicted about the trade war that the U.S. has started with Canada. Let’s be clear: any representation that Canada has been taking unfair advantage of the U.S. or that they have been treating us badly for years is a bogus characterization. In reality, the shoe is on the other foot. It’s the U.S. that has been behaving badly.

Canada hits US goods with tariffs; The rate market sees a problem

On September 8, Canada begins charging its own importers 15%, 25% and 50% on roughly 700 lines of American goods. The measure is billed as dollar for dollar, and on the arithmetic of covered trade it is. What it is not is a tax on the United States.